{"title": "PDF", "author": "PDF", "url": "https://covidindicators.cas.org/biodoc_pdf/document/pt/patent/73965851.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "i.e.blocking otherinhibitory proteins orbyenhancing atlatertimepoints,byprobably markers, etc.,maybecombined inasingleassayordevice. thereof according toanyoftheaboveclaims,whichisnotcoupledtoanyother which increases comprising atherapeutically ordiagnostically amountofatleastoneanti-VSTM5 antibody, antigen-binding VSTM5expression, comprising decreased VSTM5expression. fromthegroupconsisting orcombination therapywithconventional drugs. 233) 234) Ananti-VSTM5 vaccines the antibody, Vasculitis, Disease, Crystal Arthropathies, optionally including withcollagen innereardisease(AIED), dermatitis, chronic eosinophilic pneumonia, chronic fatigue syndrome, chronic hepatitis, chronic hypersensitivity pneumonitis, chronic inflammatory arthritis, mellitus, antagonists, "}